Stillcanna Strengthens Board with the Appointment of William Macdonald as Director
VANCOUVER, June 19, 2019,/CNW/ – StillCanna Inc.(CSE:STIL) (OTC:SCNNF) (“StillCanna” or the “Company”) is pleased to announce the appointment of William (Bill) Macdonald as an independent member of the Company’s Board of Directors.
Mr. Macdonald will be an asset to the Company by providing assistance navigating the Company’s regulatory and legal obligations. Mr. Macdonald will use his decades of knowledge and experience in the public markets to add a greater depth of knowledge to the Board.
“Mr. Macdonald is a well-respected name in the public markets,” stated Jason Dussault CEO, “we are excited to add Mr. Macdonald to the board and look forward to receiving his sound advice and direction when navigating regulatory issues.”
Mr. Macdonald is a founder and principal of Macdonald Tuskey, Corporate and Securities Lawyers, boutique security and corporate finance firm located in Vancouver, British Columbia and established in 2008. Mr. Macdonald also has public market experience as a director for several public companies listed on the TSX Venture Exchange.
In conjunction with the appointment of Mr. Macdonald as director, Denis Semenov will be stepping down from his position as director. The Company wishes to thank Mr. Semenov for his contributions to the Company and wish him all the best on his future endeavors.
About Stillcanna Inc.
StillCanna Inc.(CSE:STIL) (OTC:SCNNF)www.Stillcanna.com is a Canadian early-stage life sciences company focused on large scale CBD extraction in Europe. The Company feels its proprietary intellectual property allows it to extract CBD at a lower cost. The Company has signed an initial extraction contract in Europe to be the exclusive extractor for Dragonfly BioSciences LLC, a United Kingdom-based supplier of CBD. The Company also recently completed the acquisition of Olimax NT SP. Z .O.O, which is expected to increase the Company’s market share in the European CBD industry.
Vancouver, British Columbia–(Newsfile Corp. – April 25, 2019) – StillCanna Inc. (CSE:STIL) (OTC:SCNNF) (“StillCanna” or the “Company”) the Company is pleased to announce that further to the Company’s press release on March 18, 2019, it …
VANCOUVER, June 5, 2019 /CNW/ – StillCanna Inc. (CSE:STIL) (OTC:SCNNF) (“StillCanna” or the “Company”) is pleased to announce it has entered a strategic relationship with Sarah Yetman, an expert in the international transportation of industrial …
VANCOUVER, May 31, 2019 /CNW/ – StillCanna Inc. (CSE:STIL) (OTC:SCNNF) (“StillCanna” or the “Company”) is pleased to announce that it is trading on the OTC Markets under the symbol “SCNNF” and its shares are DTC …
Gold prices experienced a slight drop after an impressive rally throughout the summer but are still hovering well-above lows experienced in previous years. Although market bears would consider the price decrease a red flag, others …
NAVB stock is the biggest biotech stock gainer in Tuesday’s trading session after Navidea Biopharmaceuticals Inc (NYSE:NAVB) announced positive results of the first interim analysis of its ongoing phase 2B study on rheumatoid arthritis.
When a pharmaceutical company reveals information about success in a clinical trial of one of its products, then it almost always has a positive effect on the stock price. That is what happened with CVM …
1) The author of the Article, or members of the author’s immediate household or family, do not own any securities of the companies set forth in this Article. The author determined which companies would be included in this article based on my research and understanding of the sector.
2) The Article was issued on behalf of a third party, StillCanna Inc. Market Jar Media Inc. has or expects to receive sixty nine thousand canadian dollars from StillCanna Inc.’s agency of record Native Ads Inc. for 15 campaign days (10 business days).
3) Statements and opinions expressed are the opinions of the author and not Market Jar Media Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was not paid by Market Jar Media Inc. for this Article. Market Jar Media Inc. was not paid by the author to publish or syndicate this Article. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Market Jar Media Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Market Jar Media Inc. relies upon the authors to accurately provide this information and Market Jar Media Inc. has no means of verifying its accuracy.
5) Market Jar Media Inc. and its respective directors, officers and employees hold no shares for any company mentioned in the Article.